Background: Diabetic nephropathy (DN) is one of the most important complications of
diabetes mellitus. Now-a-days, cystatin C (CysC) is introduced as a new marker for …

Objective This study aimed to find the effect of serum Cystatin C in early diabetic
nephropathy. Method This study was conducted in Al Kindy Teaching Hospital during the …

Objective: To determine the diagnostic accuracy and cut-off values of serum cystatin C as
early diagnostic biomarker of diabetic kidney disease. Study Design: Cross-sectional …

Objectives. Diabetic nephropathy is one of the major complications that develop over time in
type 2 diabetes mellitus (T2DM). This prospective study was conducted to assess the …

Background The proportion of patients with end-stage renal disease caused by diabetes has
progressively increased during the last few decades. Serum creatinine level is the most …

Objectives This study was conducted to evaluate the clinical usefulness of cystatin C levels
in the serum in predicting renal impairment in patients with type 2 diabetes. Background In …

Aims We aimed to evaluate urinary CysC (cystanin c) as an early marker of diabetic
nephropathy in patients with type 2 diabetes and investigate the correlation of urinary CysC …

BACKGROUND: Serum cystatin C has been proposed as an endogenous marker of
glomerular filtration rate (GFR) because it shows a correlation with the albumin to creatinine …

Abstract Background/Aims: To evaluate cystatin C as a marker of diabetic kidney disease in
normoalbuminuric diabetic patients without chronic kidney disease (CKD). Methods: A cross …

Abstract Background and Objective: Diabetic nephropathy is the most common cause of
microvascular chronic complication of Type 2 diabetes mellitus (T2DM), which is associated …